Oramed Pharmaceuticals Inc. (ORMP) vs RxSight, Inc. (RXST)
A side-by-side comparison of Oramed Pharmaceuticals Inc. and RxSight, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ORMP
Oramed Pharmaceuticals Inc.
$4.38HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
RXST
RxSight, Inc.
$4.65HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ORMP vs RXST
growth of $100 · dividends reinvested · last 5yORMP -66.3% (-19.5%/yr)RXST -70.3% (-21.5%/yr)ORMP compounded faster over this window
ORMP RXST
ORMP vs RXST: by the numbers
- •RXST is the larger company ($192M vs $179M market cap).
- •ORMP is profitable (3202.50% net margin) while RXST runs a net loss (-36.80%).
- •ORMP pays a dividend (5.59% yield), while RXST has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | ORMP | RXST |
|---|---|---|
| P/E ratio | 1.07 | N/A |
| P/S ratio | N/A | 1.51 |
| P/B ratio | 0.56 | 0.73 |
Profitability
| Metric | ORMP | RXST |
|---|---|---|
| Gross margin | 0.65% | 77.50% |
| Operating margin | -754.40% | -43.20% |
| Net margin | 3202.50% | -36.80% |
| ROE | 55.08% | -17.83% |
| ROIC | -3.21% | -20.24% |
Dividends
| Metric | ORMP | RXST |
|---|---|---|
| Dividend yield | 5.59% | N/A |
| Payout ratio | 6.08% | N/A |
Growth (annualized)
| Metric | ORMP | RXST |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 48.85% |
| Total return CAGR (5Y) | -25.80% | -19.19% |
Frequently asked
- Does ORMP or RXST pay a bigger dividend?
- ORMP pays a dividend (5.59% yield), while RXST has no payments in the available dividend history.
- Is ORMP or RXST more profitable?
- ORMP runs the higher net margin — ORMP at 3202.50% versus RXST at -36.80%.
- How have ORMP and RXST total returns compared?
- Over the past 5 years, ORMP delivered -25.80% and RXST delivered -19.19% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Oramed Pharmaceuticals P/E ratioOramed Pharmaceuticals dividend yieldOramed Pharmaceuticals ROERxSight ROEOramed Pharmaceuticals operating marginRxSight operating marginOramed Pharmaceuticals revenue growthRxSight revenue growthOramed Pharmaceuticals free cash flowRxSight free cash flow
Oramed Pharmaceuticals & RxSight appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.